Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE)

NCT02134028 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2282

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Dupilumab

Sponsor

Sanofi

Collaborators

[object Object]